Detalhe da pesquisa
1.
Predictors of thrombosis during VV ECMO: an analysis of 9809 patients from the ELSO registry.
J Thromb Thrombolysis
; 57(3): 345-351, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38095743
2.
pepsickle rapidly and accurately predicts proteasomal cleavage sites for improved neoantigen identification.
Bioinformatics
; 37(21): 3723-3733, 2021 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34478497
3.
Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2.
J Virol
; 94(13)2020 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32303592
4.
PD-1 Limits IL-2 Production and Thymic Regulatory T Cell Development.
Immunohorizons
; 8(3): 281-294, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38551395
5.
An omic and multidimensional spatial atlas from serial biopsies of an evolving metastatic breast cancer.
Cell Rep Med
; 3(2): 100525, 2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35243422
6.
Putatively cancer-specific exon-exon junctions are shared across patients and present in developmental and other non-cancer cells.
NAR Cancer
; 2(1): zcaa001, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34316681
7.
Burden of tumor mutations, neoepitopes, and other variants are weak predictors of cancer immunotherapy response and overall survival.
Genome Med
; 12(1): 33, 2020 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32228719
8.
Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia.
Nat Commun
; 10(1): 5455, 2019 11 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31784538
9.
Author Correction: Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia.
Nat Commun
; 13(1): 3471, 2022 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35710794